These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 37022163

  • 1. Reconstitution and Mutagenesis of Avian Infectious Laryngotracheitis Virus from Cosmid and Yeast Centromeric Plasmid Clones.
    Spatz S, García M, Fuchs W, Loncoman C, Volkening J, Ross T, Riblet S, Kim T, Likens N, Mettenleiter T.
    J Virol; 2023 Apr 27; 97(4):e0140622. PubMed ID: 37022163
    [Abstract] [Full Text] [Related]

  • 2. Genetic Diversity of Infectious Laryngotracheitis Virus during In Vivo Coinfection Parallels Viral Replication and Arises from Recombination Hot Spots within the Genome.
    Loncoman CA, Hartley CA, Coppo MJC, Vaz PK, Diaz-Méndez A, Browning GF, García M, Spatz S, Devlin JM.
    Appl Environ Microbiol; 2017 Dec 01; 83(23):. PubMed ID: 28939604
    [Abstract] [Full Text] [Related]

  • 3. Pathogenic and Transmission Potential of Wildtype and Chicken Embryo Origin (CEO) Vaccine Revertant Infectious Laryngotracheitis Virus.
    Perez-Contreras A, Barboza-Solis C, Najimudeen SM, Checkley S, Meer FV, Joseph T, King R, Ravi M, Peters D, Fonseca K, Gagnon CA, Ojkic D, Abdul-Careem MF.
    Viruses; 2021 Mar 24; 13(4):. PubMed ID: 33805117
    [Abstract] [Full Text] [Related]

  • 4. Single Nucleotide Polymorphism Genotyping Analysis Shows That Vaccination Can Limit the Number and Diversity of Recombinant Progeny of Infectious Laryngotracheitis Viruses from the United States.
    Loncoman CA, Hartley CA, Coppo MJC, Browning GF, Beltrán G, Riblet S, Freitas CO, García M, Devlin JM.
    Appl Environ Microbiol; 2018 Dec 01; 84(23):. PubMed ID: 30242009
    [Abstract] [Full Text] [Related]

  • 5. Newcastle disease virus (NDV) recombinants expressing infectious laryngotracheitis virus (ILTV) glycoproteins gB and gD protect chickens against ILTV and NDV challenges.
    Zhao W, Spatz S, Zhang Z, Wen G, Garcia M, Zsak L, Yu Q.
    J Virol; 2014 Aug 01; 88(15):8397-406. PubMed ID: 24829337
    [Abstract] [Full Text] [Related]

  • 6. The UL47 gene of avian infectious laryngotracheitis virus is not essential for in vitro replication but is relevant for virulence in chickens.
    Helferich D, Veits J, Teifke JP, Mettenleiter TC, Fuchs W.
    J Gen Virol; 2007 Mar 01; 88(Pt 3):732-742. PubMed ID: 17325345
    [Abstract] [Full Text] [Related]

  • 7. Glycoprotein-C-gene-deleted recombinant infectious laryngotracheitis virus expressing a genotype VII Newcastle disease virus fusion protein protects against virulent infectious laryngotracheitis virus and Newcastle disease virus.
    Wei X, Shao Y, Han Z, Sun J, Liu S.
    Vet Microbiol; 2020 Nov 01; 250():108835. PubMed ID: 33011664
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Replication-independent reduction in the number and diversity of recombinant progeny viruses in chickens vaccinated with an attenuated infectious laryngotracheitis vaccine.
    Loncoman CA, Hartley CA, Coppo MJC, Browning GF, Quinteros JA, Diaz-Méndez A, Thilakarathne D, Fakhri O, Vaz PK, Devlin JM.
    Vaccine; 2018 Sep 11; 36(38):5709-5716. PubMed ID: 30104116
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Safety and vaccine efficacy of a glycoprotein G deficient strain of infectious laryngotracheitis virus delivered in ovo.
    Legione AR, Coppo MJ, Lee SW, Noormohammadi AH, Hartley CA, Browning GF, Gilkerson JR, O'Rourke D, Devlin JM.
    Vaccine; 2012 Nov 26; 30(50):7193-8. PubMed ID: 23084851
    [Abstract] [Full Text] [Related]

  • 19. Comparative in vivo safety and efficacy of a glycoprotein G-deficient candidate vaccine strain of infectious laryngotracheitis virus delivered via eye drop.
    Coppo MJ, Noormohammadi AH, Hartley CA, Gilkerson JR, Browning GF, Devlin JM.
    Avian Pathol; 2011 Aug 26; 40(4):411-7. PubMed ID: 21812721
    [Abstract] [Full Text] [Related]

  • 20. Attenuated infectious laryngotracheitis virus vaccines differ in their capacity to establish latency in the trigeminal ganglia of specific pathogen free chickens following eye drop inoculation.
    Thilakarathne DS, Coppo MJC, Hartley CA, Diaz-Méndez A, Quinteros JA, Fakhri O, Vaz PK, Devlin JM.
    PLoS One; 2019 Aug 26; 14(3):e0213866. PubMed ID: 30921344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.